Plenary Sessions

The 2020 AANEM Annual Meeting Plenary Topic will be "Emergent Therapies in Neuromuscular Diseases."

Wednesday - Plenary 1

John Day, MD, PhD - Olney Lecture
Lecture Topic - Art, Science and Engineering of Outcome Measures for Neuromuscular Disease

• Professor of Neurology and Pediatrics
  Director, Division of Neuromuscular Medicine, Stanford University

Thursday - Plenary 2
 

Charlotte Sumner, MD
Lecture Topic – The Success and Challenges of Gene Targeted Therapeutics in SMA

• Professor of Neurology and Neuroscience, Johns Hopkins University School of Medicine

Craig McDonald, MD
Lecture Topic – Dystrophinopathy

• Professor and Chair
  Department of Physical Medicine and Rehabilitation
• Professor of Pediatrics
  Director of MDA Neuromuscular Disease Clinics
  UC Davis

Friday - Plenary 3

Gil Wolfe, MD - Reiner Lecture
Lecture Topic – Therapeutic Landscape and Novel Therapies for Myasthenia Gravis

• University at Buffalo Department of Neurology, Jacobs School of Medicine & Biomedical Sciences
• Professor and Chairman, Irvin and Rosemary Smith Chair of Neurology

Friday Plenary cont.

Luis Querol, MD, PhD
Lecture Topic -
Antibodies in Inflammatory Neuropathies: What to Test, How to Test, Why to Test

• Attending Neurologist, Neuromuscular BCN, Barcelona, Spain

Saturday - Plenary 4

Carolina Barnett-Tapia, MD, PhD Surinderjit Singh Young Lectureship Award Speaker

Lecture Topic - Assessing New Health Technologies/Treatments

• Assistant Professor, Neurology, Medicine, University of Toronto
• Physician - Active Staff, Division of Neurology, University Health Network
• Member, Medical Advisory Board, Myasthenia Gravis Society of Canada, Canada
• Assistant Professor, Institute Health policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto

Merit Cudkowicz, MD - 
Lambert Lecture

​Lecture Topic - ALS Therapeutics:  New Treatments and New Approaches

• Chief, Neurology Department, Massachusetts General Hospital
• Director, Sean Ml Healey & AMG Center for ALS
• Director, Neurological Clinical Research Institute